JP2023157965A5 - - Google Patents

Download PDF

Info

Publication number
JP2023157965A5
JP2023157965A5 JP2023134734A JP2023134734A JP2023157965A5 JP 2023157965 A5 JP2023157965 A5 JP 2023157965A5 JP 2023134734 A JP2023134734 A JP 2023134734A JP 2023134734 A JP2023134734 A JP 2023134734A JP 2023157965 A5 JP2023157965 A5 JP 2023157965A5
Authority
JP
Japan
Prior art keywords
mrna
expression level
atopic dermatitis
subject
genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023134734A
Other languages
English (en)
Japanese (ja)
Other versions
JP7743475B2 (ja
JP2023157965A (ja
Filing date
Publication date
Priority claimed from JP2020081473A external-priority patent/JP2021175381A/ja
Application filed filed Critical
Priority to JP2023134734A priority Critical patent/JP7743475B2/ja
Publication of JP2023157965A publication Critical patent/JP2023157965A/ja
Publication of JP2023157965A5 publication Critical patent/JP2023157965A5/ja
Application granted granted Critical
Publication of JP7743475B2 publication Critical patent/JP7743475B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023134734A 2020-05-01 2023-08-22 アトピー性皮膚炎の検出方法 Active JP7743475B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023134734A JP7743475B2 (ja) 2020-05-01 2023-08-22 アトピー性皮膚炎の検出方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020081473A JP2021175381A (ja) 2020-05-01 2020-05-01 アトピー性皮膚炎の検出方法
JP2023134734A JP7743475B2 (ja) 2020-05-01 2023-08-22 アトピー性皮膚炎の検出方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020081473A Division JP2021175381A (ja) 2020-05-01 2020-05-01 アトピー性皮膚炎の検出方法

Publications (3)

Publication Number Publication Date
JP2023157965A JP2023157965A (ja) 2023-10-26
JP2023157965A5 true JP2023157965A5 (enExample) 2025-02-18
JP7743475B2 JP7743475B2 (ja) 2025-09-24

Family

ID=78300066

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020081473A Pending JP2021175381A (ja) 2020-05-01 2020-05-01 アトピー性皮膚炎の検出方法
JP2023134734A Active JP7743475B2 (ja) 2020-05-01 2023-08-22 アトピー性皮膚炎の検出方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020081473A Pending JP2021175381A (ja) 2020-05-01 2020-05-01 アトピー性皮膚炎の検出方法

Country Status (1)

Country Link
JP (2) JP2021175381A (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102445680B1 (ko) * 2013-08-30 2022-09-20 인터디지탈 패튼 홀딩스, 인크 애플리케이션 특정 액세스 제어 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005110602A (ja) * 2003-10-09 2005-04-28 Sumitomo Pharmaceut Co Ltd アトピー性皮膚炎の疾患マーカー及びその利用
EP3719138B1 (en) * 2016-07-08 2022-09-21 Kao Corporation Method for preparing nucleic acid sample
US11911012B2 (en) * 2017-03-03 2024-02-27 Children's Hospital Medical Center Non-invasive methods for skin sample collection and analysis

Similar Documents

Publication Publication Date Title
Bellet et al. The 6-minute walk test in outpatient cardiac rehabilitation: validity, reliability and responsiveness—a systematic review
Pinto et al. Predicting respiratory insufficiency in amyotrophic lateral sclerosis: the role of phrenic nerve studies
Ingle et al. Prognostic value of the VE/VCO2 slope calculated from different time intervals in patients with suspected heart failure
Ranucci et al. The easier, the better: age, creatinine, ejection fraction score for operative mortality risk stratification in a series of 29,659 patients undergoing elective cardiac surgery
Lefaucheur et al. The value of electrochemical skin conductance measurement using Sudoscan® in the assessment of patients with familial amyloid polyneuropathy
JP2011516046A5 (enExample)
JP2021180654A5 (enExample)
CN113314211A (zh) 一种基于粪便微生物标志物和人dna含量的结直肠癌风险评估的方法及应用
Yip et al. Catching “Early” COPD–the diagnostic conundrum
Shah et al. Changes in estimated right ventricular systolic pressure predict mortality and pulmonary hypertension in a cohort of scleroderma patients
Guo et al. Inclusion of frailty improved performance of delirium prediction for elderly patients in the cardiac intensive care unit (D-FRAIL): a prospective derivation and external validation study
Kim et al. Patient-specific molecular response dynamics can predict the possibility of relapse during the second treatment-free remission attempt in chronic myelogenous leukemia
Travassos et al. Fat-free mass depletion in patients with COPD in Brazil: development of a new cutoff point and its relation with mortality and extrapulmonary manifestations
Colwell et al. Calculated versus measured MVV-surrogate marker of ventilatory CPET
Jensen et al. A statistical rationale for the use of forced expired volume in 6 s
JP2024161911A5 (enExample)
Davis et al. Skin microbiome differences in pancreatic adenocarcinoma, other cancers, and healthy controls: a pilot study
JP2011254990A (ja) 漢方医学的体質分類方法
Hekkala et al. Reproducibility of computerized measurements of QT interval from multiple leads at rest and during exercise
JP2023162292A5 (enExample)
Ng et al. WEKA machine learning classification in identifying autonomic dysfunction parameters associated with ACE insertion/deletion genotypes
CN120350166B (zh) 白地霉作为生物标志物在心力衰竭诊断中的应用
Papaporfyriou et al. Noninvasive evaluation of airway inflammation in patients with severe asthma
Paramalingam et al. 089 3D Computational Modelling of Immune Interaction and Epidermal Homeostasis in Psoriasis
Bianchi et al. Burnout and the hypothalamic-pituitary-thyroid axis: A methodological comment